Nifedipina Generis (Nifedipine)

Nifedipine blocks L‑type calcium channels in vascular smooth‑muscle, preventing calcium entry that triggers contraction. This causes arterial relaxation, reduces peripheral resistance, lowers blood pressure, and enhances coronary blood flow, which helps relieve chest pain.

The exact dose is individualized. A qualified prescriber determines the appropriate strength, frequency and duration based on the patient’s condition, response to therapy and any co‑existing medical issues.

Safety data are limited. Nifedipine should be used during pregnancy or lactation only if the potential benefit justifies any possible risk to the fetus or infant, and under close medical supervision.

Enquiries are submitted via the product page at gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nifedipine belongs to the dihydropyridine calcium‑channel blocker class, offering potent arterial vasodilation. Compared with beta‑blockers, it does not reduce heart rate, and unlike ACE inhibitors, it does not affect the renin‑angiotensin system. It is often chosen when a rapid blood‑pressure‑lowering effect is desired or when patients cannot tolerate other classes.

Store the tablets at ambient temperature below 25 °C, in the original blister pack or container, protected from moisture, heat and direct light. Keep out of reach of children and do not use after the expiry date printed on the packaging.

The product is taken orally. Swallow the tablet whole with a full glass of water, preferably at the same time each day. Do not crush, chew or split the tablet unless specifically instructed by a healthcare professional.

Serious adverse events include severe hypotension, which can cause dizziness or fainting, cardiac arrhythmias, and rare cases of liver injury. Patients should seek immediate medical attention if they experience sudden weakness, chest pain, irregular heartbeat or signs of liver dysfunction such as jaundice.

Contraindications include known hypersensitivity to nifedipine or any excipients, severe aortic stenosis, uncontrolled heart failure, and cardiogenic shock. Caution is also advised in patients with significant hepatic impairment or those taking interacting medications that could raise nifedipine levels.